Evidence map›Paper›PMID 37740433›Full record

ArticleJournal of clinical hypertension (Greenwich, Conn.)2023

Uncontrolled blood pressure and therapeutic inertia in treated hypertensive patients: A retrospective cohort study using a UK general practice database.

Céline Darricarrere, Emmanuelle Jacquot, Stéphanie Bricout, Caroline Louis, Marc Bénard, Neil R Poulter

Registry-linked trialOpen access · diamondAbstract read
In one paragraph

Article in Journal of clinical hypertension (Greenwich, Conn.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07218198 (A Stepped Wedged, Cluster Randomized Clinical Trial to Evaluate the Efficacy of a Clinical Decision Support Tool in the Treatment of Uncontrolled Hypertension), which is not on this map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07218198 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

A Stepped Wedged, Cluster Randomized Clinical Trial to Evaluate the Efficacy of a Clinical Decision Support Tool in the Treatment of Uncontrolled Hypertension

TypeinterventionalSponsorThe Cleveland ClinicRan2026 to 2027Enrolled168ConditionsHypertension, Hypertension (HTN), Blood Pressure, High, Blood Pressure ControlArmsStandard medical treatment, Clinical Decision Support Tool
3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Céline DarricarrerePharmacoepidemiology and Real World Evidence Department, Servier Laboratories, Suresnes, France.ORCID 0000-0002-5306-6906
Emmanuelle JacquotPharmacoepidemiology and Real World Evidence Department, Servier Laboratories, Suresnes, France.
Stéphanie BricoutCardiovascular & Metabolic Diseases Therapeutic Area & Life Cycle Management, Servier Laboratories, Suresnes, France.
Caroline LouisCardiovascular & Metabolic Diseases Therapeutic Area & Life Cycle Management, Servier Laboratories, Suresnes, France.
Marc BénardAixial, Boulogne Billancourt, France.
Neil R PoulterImperial Clinical Trials Unit, Imperial College London, London, UK.
Servier (France) · FRImperial College London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Uncontrolled blood pressure (BP) and therapeutic inertia pose significant challenges in effectively managing hypertension. This study objective was to quantify levels of uncontrolled BP and therapeutic inertia among patients treated for hypertension in primary care. This retrospective cohort study used data recorded by general practitioners from the UK Clinical Practice Research Datalink database. Adults with primary hypertension who received a recorded prescription for any antihypertensive drug between January 2015 and June 2017 (index date) were included, with a follow-up of 18 months. Primary outcomes included the percentage of patients with uncontrolled BP (defined as systolic BP ≥140 mmHg or diastolic BP ≥90 mmHg) and of apparent therapeutic inertia (defined as two consecutive uncontrolled BP records without treatment change) during follow-up. Finally, of 581 260 patients receiving antihypertensive drug(s), 37.2% (n = 216 014) had uncontrolled BP at the index date and 30.3% (n = 175 955) had no record of BP at this date. During follow-up, 59.2% had ≥1 record of uncontrolled BP, in 22% all records showed uncontrolled BP, and 12.8% had no record of BP. Among those with uncontrolled BP at the index date, 72.9% had ≥1 record of uncontrolled BP during follow-up, and in 28.3% all records showed uncontrolled BP. Therapeutic inertia was observed in 33.1% of patients overall, and in 55.7% of those with uncontrolled BP at the index date. In conclusion, BP recording was infrequent, possibly reflecting both a low frequency of measurement and potential under-recording. Uncontrolled BP and therapeutic inertia appear to be widespread in UK general practice.

Indexed as

General PracticeHypertensionAdultAntihypertensive AgentsBlood PressureHumansRetrospective StudiesUnited KingdomAntihypertensive Agentsantihypertensive agentsblood pressurecohort studiesdatabasehypertensionphysicianspractice patternsprimary health careretrospective studiestherapeutic inertia

Identifiers

PMID37740433
PMCPMC10560967
OpenAlexW4386979683

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.